Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Conditions:   Recurrent Head and Neck Squamous Cell Carcinoma;   Head and Neck Cancer Stage IV Interventions:   Drug: Nivolumab + Paclitaxel;   Drug: Cetuximab + Paclitaxel Sponsors:   Grupo Español de Tratamiento de Tumores de Cabeza y Cuello;   Bristol-Myers Squibb;   Apices Soluciones S.L. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials